Skip to content

Editorial team & process

Every protocol on The Biohacking Bible passes through the same review pipeline before publication, and every page carries a single editorial credit line. This page explains who that credit refers to and what it means.

The editorial credit

Pages are credited to The Biohacking Bible editorial team. That credit isn't a single author byline. It reflects a small editorial process applied to every protocol: a researcher drafts; a reviewer checks the cited evidence; the build pipeline enforces ASA-safe language; and a final pass confirms the page meets our editorial principles below.

We don't claim individual named clinicians on each page. None of the team are practising UK-registered clinicians, and we won't imply otherwise. Our value is journalistic and editorial: translating published human research into ASA-safe plain English, grading evidence honestly, and being transparent about what we don't know.

For anything that materially affects your health, see a UK-registered clinician. We exist alongside that relationship, not as a substitute for it. Full disclosure on our medical disclaimer.

Our editorial principles

  • Every protocol cites human research wherever it exists.
  • Evidence grades A–D reflect the strength of human evidence, not popularity.
  • Pages are reviewed at least annually, and sooner when NHS / NICE / MHRA / FSA guidance changes.
  • Banned-claim regex blocks 'cures', 'treats disease', 'guaranteed', 'prevents disease', 'miracle' at the build step.
  • We don't sell supplements, devices, or paid placements.
  • Corrections go in-line with a dated note. Material rewrites are tracked in git history.

How a protocol gets reviewed

  1. Draft. Researcher writes from the published human evidence. Each draft maps claims to specific studies (DOI / PubMed) before it leaves draft state.
  2. Evidence review. Reviewer checks every cited study against the claim it supports. Citations the prose can't back are removed; claims the literature won't support are softened or cut.
  3. ASA / MHRA framing pass. Specific check against the banned-phrase regex (editorial policy) and against the language patterns the ASA has historically ruled against in health advertising.
  4. Build pipeline. Frontmatter is validated with zod; the banned-phrase regex runs at every build; missing lastReviewed dates fail the build outright.
  5. Publication. Date stamped as lastReviewed. From this point any material change triggers a dated correction note in line.

Review cadence

Every protocol is re-reviewed at least once a year. We bring the review forward when:

  • NHS, NICE, MHRA, or FSA publish guidance touching the topic.
  • A major systematic review or RCT changes the dose / effect / safety picture.
  • A reader reports a substantive correction we can verify.
  • A regulatory event (e.g. MHRA reclassification) changes the legal framing.

The Last reviewed date on each protocol page is the date of the most recent end-to-end review, not merely the date a typo was fixed.

What we are not

  • Not your clinician. Even when we describe what published research has shown about an intervention, we're describing the literature — not advising you personally.
  • Not a retailer. We sell nothing. No affiliate links on protocol content.
  • Not anonymous. Contact us at [email protected].
  • Not infallible. See our corrections policy.

Submit a correction

If you spot an error — a misquoted study, a regulatory update we've missed, a broken link, anything — email [email protected] with the page URL and what you think is wrong. We aim to respond within five working days. Material corrections appear as a dated note on the affected page.

Conflicts of interest

No editorial contributor holds equity in supplement brands, longevity-product companies, or biohacking device manufacturers. We do not accept gifted samples for review. Where a UK-registered clinician would face a conflict-of-interest declaration on a topic we cover (lipid-lowering, hormone therapy, controlled drugs), we describe the published research and signpost to clinical care; we don't make individual recommendations.

See also: editorial policy, evidence-grading methodology, corrections policy, medical disclaimer.